Bank Of New York Mellon Corp Pmv Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.17 - $12.95 $1 Million - $1.59 Million	122,799 New	122,799 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $202,646 - $305,391	17,776 Added 16.98%	122,453 $1.46 Million
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $226,393 - $550,163	24,528 Added 30.6%	104,677 $1.49 Million
Q1 2022 May 11, 2022	SELL	$14.86 - $23.55 $3,180 - $5,039	-214 Reduced 0.27%	80,149 $1.67 Million
Q4 2021 Feb 11, 2022	BUY	$19.99 - $30.24 $59,710 - $90,326	2,987 Added 3.86%	80,363 $1.86 Million
Q3 2021 Nov 12, 2021	BUY	$26.84 - $36.58 $313,115 - $426,742	11,666 Added 17.75%	77,376 $2.31 Million
Q2 2021 Aug 11, 2021	BUY	$28.01 - $36.01 $708,568 - $910,944	25,297 Added 62.6%	65,710 $2.24 Million
Q1 2021 May 13, 2021	SELL	$30.66 - $49.5 $27,011 - $43,609	-881 Reduced 2.13%	40,413 $1.33 Million
Q4 2020 Feb 09, 2021	BUY	$31.86 - $61.51 $1.32 Million - $2.54 Million	41,294 New	41,294 $2.54 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.